Final Results from REASON, a Registry for the Epidemiologic and Scientific evaluation of EGFR mutation status in newly diagnosed NSCLC patients stage IIIB/IV in Germany.

6. Juni 2014

Schuette, W., Eberhardt, W., Graf von der Schulenburg, J.-M., Dietel, M., Schirmacher, P., Zaun, S., Zirrgiebel, U., Thomas, M., 2014.

Oncol Res Treat, Deutscher Krebskongress, Berlin 37 (suppl 1) (ID 209), 89. doi:10.1159/000360634